Significance of p21 expression in oral squamous cell carcinoma
Not Applicable
- Conditions
- oral squamous cell carcinoma
- Registration Number
- JPRN-UMIN000052042
- Lead Sponsor
- Department of Medical Laboratory Sciences, School of Allied Health Sciences Kitasato University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
We excluded studies published in languages other than Japanese or English as well as those that used cultured cells or animal experiments, case reports, review articles, and papers lacking data on relationships between clinicopathological factors and p21 expression.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We will performe a meta-analysis to evaluate the associations between clinicopathological factors and the p21 expression in OSCC.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link p21 expression to prognosis in oral squamous cell carcinoma?
How does p21 expression compare to other biomarkers like p53 or Ki-67 in predicting oral cancer outcomes?
Are there targeted therapies for p21-related pathways in oral squamous cell carcinoma treatment?
What adverse events are associated with p21-targeted interventions in head and neck cancers?
How does p21 expression correlate with resistance to standard-of-care treatments in oral cancer?